One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study
References (16)
The migraine syndrome in children and adolescents
Pediatr Neurol
(1986)- et al.
Childhood migraine in general practice: Clinical features and characteristics
Cephalalgia
(1992) - et al.
Headache in children and adolescents
Pain Man Child
(1997) - et al.
Classification of pediatric migraine: Proposed revisions to the IHS criteria
Headache
(1995) - et al.
Demographic and migraine characteristics of adolescent patients: The Glaxo Wellcome Adolescent Clinical Trials Database
American Headache Society Annual Scientific Meeting
(June 22-26, 2000) When it comes to migraine, children are not small adults
Drugs Ther Perspect
(1999)Migraine in children: Guidelines for treatment
CNS Drugs
(1998)Appropriate migraine therapy for children and adolescents
Cephalagia
(1999)
There are more references available in the full text version of this article.
Cited by (64)
Pediatric Migraine: An Update
2019, Neurologic ClinicsPredictors of Triptan Response in Pediatric Migraine
2016, Pediatric NeurologySumatriptan nasal spray in the acute treatment of migraine in adolescents and children
2007, European Journal of Paediatric NeurologyCitation Excerpt :The in- and exclusion criteria and the study demographics were almost identical in all seven trials. One trial studied children aged 6–9 years,10 one both children and adolescents aged 8–17 years,13 and in the five other trials adolescents aged 12–17 years were enrolled.11,12,14,15,26 In all trials, subjects with at least a 6-months history of moderate or severe migraine and having at least two migraine attacks per month were included.
Drug-related side effects and adverse reactions in the treatment of migraine: a bibliometric and visual analysis
2024, Frontiers in NeurologyPharmacotherapy for acute migraines in children and adolescents
2019, Expert Opinion on Pharmacotherapy
Copyright © 2000 Published by Elsevier Inc.